Canada Life’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-25,207
| Closed | -$4.17M | – | 2574 |
|
|
2021
Q2 | $4.17M | Buy |
25,207
+163
| +0.7% | +$27.2K | 0.01% | 767 |
|
|
2021
Q1 | $3.83M | Sell |
25,044
-11,313
| -31% | -$1.54M | 0.01% | 791 |
|
|
2020
Q4 | $4.56M | Sell |
36,357
-1,512
| -4% | -$169K | 0.01% | 800 |
|
|
2020
Q3 | $3.84M | Sell |
37,869
-1,420
| -4% | -$145K | 0.01% | 800 |
|
|
2020
Q2 | $3.82M | Sell |
39,289
-1,126
| -3% | -$105K | 0.01% | 777 |
|
|
2020
Q1 | $3.35M | Buy |
40,415
+10,054
| +33% | +$981K | 0.01% | 752 |
|
|
2019
Q4 | $3.35M | Buy |
+30,361
| New | +$3.12M | 0.01% | 870 |
|
|
2019
Q3 | – | Sell |
-34,109
| Closed | -$3.39M | – | 2588 |
|
|
2019
Q2 | $3.39M | Sell |
34,109
-1,878
| -5% | -$179K | 0.01% | 901 |
|
|
2019
Q1 | $3.96M | Buy |
35,987
+320
| +0.9% | +$33.4K | 0.01% | 725 |
|
|
2018
Q4 | $3.04M | Buy |
35,667
+3,378
| +10% | +$342K | 0.01% | 814 |
|
|
2018
Q3 | $3.56M | Buy |
32,289
+2,640
| +9% | +$275K | 0.01% | 826 |
|
|
2018
Q2 | $2.77M | Buy |
29,649
+23,745
| +402% | +$2.04M | 0.01% | 958 |
|
|
2018
Q1 | $491K | Hold |
5,904
| – | – | ﹤0.01% | 1738 |
|
|
2017
Q4 | $536K | Buy |
5,904
+1,203
| +26% | +$100K | ﹤0.01% | 1713 |
|
|
2017
Q3 | $356K | Hold |
4,701
| – | – | ﹤0.01% | 1801 |
|
|
2017
Q2 | $352K | Hold |
4,701
| – | – | ﹤0.01% | 1786 |
|
|
2017
Q1 | $306K | Hold |
4,701
| – | – | ﹤0.01% | 1818 |
|
|
2016
Q4 | $260K | Buy |
4,701
+1,501
| +47% | +$82.4K | ﹤0.01% | 1840 |
|
|
2016
Q3 | $181K | Hold |
3,200
| – | – | ﹤0.01% | 1930 |
|
|
2016
Q2 | $133K | Hold |
3,200
| – | – | ﹤0.01% | 2001 |
|
|
2016
Q1 | $137K | Hold |
3,200
| – | – | ﹤0.01% | 1561 |
|
|
2015
Q4 | $145K | Hold |
3,200
| – | – | ﹤0.01% | 1494 |
|
|
2015
Q3 | $125K | Hold |
3,200
| – | – | ﹤0.01% | 1540 |
|
|
2015
Q2 | $116K | Buy |
+3,200
| New | +$101K | ﹤0.01% | 1753 |
|
Other funds holding PRAH
Canada Life's PRAH Position: Q3 2021 in Review
Canada Life sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 25,207 shares — an estimated $4.17M sold.
Canada Life first reported a position in PRAH in Q2 2015 and held it in 24 quarters. The position peaked at $4.56M in Q4 2020. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Canada Life reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Canada Life sold 25,207 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $4.17M.
- Canada Life first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 24 quarters.
- Canada Life's PRA Health Sciences, Inc. position peaked at $4.56M in Q4 2020.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Canada Life's 13F filing for Q3 2021, filed 15 Nov 2021.